comparemela.com

Latest Breaking News On - Specialty pharma - Page 1 : comparemela.com

Medios : Unternehmenspräsentation - MarketScreener

Medios : Unternehmenspräsentation - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Company presentationFrankfurt stock exchange prime standardSpecialty pharmaceuticalsEuropean specialty pharma platformSpecialty pharmaInvestment highlightsFrankfurt stock exchangePrime standard

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

EQS-News: Medios AG / Key word: Quarterly / Interim Statement/Quarter Results Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year.

Claudia nickolausMatthias gaertnerGoldman sachsMedios groupCeban pharmaceuticalsbvSpecialty pharma solutionsCeban pharmaceuticalsSpecialty pharmaPharmaceutical supplyPatient specific therapiesBlister gmbhChief executive officerEuropean specialty pharmaSpecific therapiesWarburg highlightsHalf year financial report

TELES Informationstechnologien : Annual Financial Statements 2023

Translation - the German version is authoritative Annual Report and .

Arzneimittel gmbRechenzentrum gmbMarktprognose apothekenHealth gmbCarrier solutionsGroup management boardInternational financial reporting standardsInternational monetary fundResearch developmentGerman commercial codeSupervisory boardGerman accounting standardSpecialty pharmaUnified communicationGerman clinicReproductive medicine gmbh

60 Degrees Pharmaceuticals to Sponsor Pilot Study of

60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease..

United statesPatrick gaynesSheilaa burkeUnited states armyExchange commissionMateriel development activityDegrees pharmaceuticals incDrug administrationDegrees pharmaceuticalsCompany typeWalter reed army institute of researchCarolina state universityNorth carolina state universityCanine babesiosis pilotInstitutional animal careUse committee

Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO

～Hidemasa s appointment bolsters Aculys position as a leader in the field of CNS in Japan and Asia～

Minato kuUnited statesTakeshi takahashiAculys pharmaHidemasa tanigakiNihon pharmaceutical co ltdTakeda pharmaceutical companyPrnewswire aculys pharma incAculys pharma incChief executive officerRepresentative directorSales directorSpecialty pharmaRare hematologyGastrointestinal disease business unitExecutive chairperson

vimarsana © 2020. All Rights Reserved.